Bret Freudenthal, professor of biochemistry and molecular biology at University of Kansas Medical Center and research partner in cancer biology at Univeristy of Kansas Cancer Center, will present the Biochemistry and Molecular Biophysics Seminar. He will present "Mechanisms of nucleotide selection by telomerase: implications for cancer therapy."